Odds of cardiovascular mortality 14.8% higher in black Americans with both conditions.
HIV retransplant recipients have increased risk of death and graft loss versus HIV re-KT patients
Increased 30-day morbidity for black race, bladder and urinary diversion operations.
The debate continues on how best to use parathyroidectomy to treat severe SHPT.
During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.
For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks.
High potassium levels associated with the use of renin-angiotensin-aldosterone system inhibitors limit their use in CKD patients.
A higher allopurinol dose was protective against renal failure in elderly allopurinol recipients.
Does not improve overall survival in metastatic castration-resistant prostate cancer.
Phosphorus targets in patients with chronic kidney disease stage 3 to 4 should be below 4.3 mg/dL, researchers report.
Hyperphosphatemia is present in many who say following diets and binder schedules is easy.
Calcifediol formulation is indicated for CKD stage 3 or 4 patients with secondary hyperparathyroidism associated with vitamin D insufficiency.
Shows the strongest correlation between biochemical recurrence and subsequent systemic progression.
Researchers find an increased risk of death among patients.
Most patients discharged home within first 6 hours after surgery; none readmitted.
- Blacks With Diabetes and CKD Have Higher CVD Risk
- Worse Re-transplant Outcomes for HIV Positive Patients
- Race, Procedure Type Influence Morbidity in Pediatric Surgery Patients
- Parathyroidectomy Rates Stable Despite Changes in Medical Therapy
- Early Recurrence After Laparoscopic Radical Cystectomy Explored
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)